Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$522.38 +6.04 (+1.17%)
At close: Sep 24, 2026 · 4:00 PM EDT

Vertex Pharmaceuticals (VRTX) EV to CFO (2009 - 2026)

Vertex Pharmaceuticals (VRTX) posted EV to CFO of 104.85 for Q2 2026, up 40.93% on a QoQ basis from 74.4 in Q1 2026, and up 4.45% year-over-year from 100.38 in Q2 2025.

Analysis

Vertex Pharmaceuticals (VRTX) EV to CFO (2009 - 2026) Analysis & Trends

Vertex Pharmaceuticals has reported EV to CFO for 18 years, with the latest figure at 104.85 in Q2 2026.

  • On a quarterly basis, EV to CFO rose 4.45% year-over-year to 104.85 in Q2 2026; TTM through Jun 2026 was 27.49, a 1.86% decrease from a year earlier, with the FY2025 full-year figure at 29.89, up 115.12% from the prior year.
  • EV to CFO was 104.85 for Q2 2026 at Vertex Pharmaceuticals, up from 74.4 in the prior quarter.
  • The five-year high for EV to CFO was 399.13 in Q4 2023, with the low at 30.67 in Q2 2024.
  • Average EV to CFO over 5 years is 103.47, with a median of 74.95 recorded in 2024.
  • The sharpest annual moves came in 2023 and 2024: EV to CFO soared 578.45% in 2023, then tumbled 143.78% in 2024.
  • Over 5 years, EV to CFO stood at 58.83 in 2022, then jumped by 578.45% to 399.13 in 2023, then sank by 58.28% to 166.53 in 2024, then jumped by 30.88% to 217.95 in 2025, then plunged by 51.9% to 104.85 in 2026.
  • The last three EV to CFO figures came in at 104.85 (Q2 2026), 74.4 (Q1 2026), and 217.95 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn
10 Bristol Myers Squibb 124.95 Bn 113.89 Bn 9.25 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 104.85
Mar 31, 2026 74.40
Dec 31, 2025 217.95
Sep 30, 2025 75.05
Jun 30, 2025 100.38
Mar 31, 2025 144.56
Dec 31, 2024 166.53
Sep 30, 2024 82.75
Jun 30, 2024 -30.67
Mar 31, 2024 74.85
Dec 31, 2023 399.13
Sep 30, 2023 61.28
Jun 30, 2023 70.07
Mar 31, 2023 78.59
Dec 31, 2022 58.83
Sep 30, 2022 67.54
Jun 30, 2022 55.18
Mar 31, 2022 61.14
Dec 31, 2021 48.60
Sep 30, 2021 42.61
API Access

Vertex Pharmaceuticals EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=VRTX&period=max&api_key=YOUR_API_KEY